Jessica is by far the most caring person ever
For those using both medications, understanding these differences is important for achieving the best possible outcomes
The difference between the groups as measured by a test looking at someones tremors and rigidity was small, almost but not quite reaching what is deemed to be a clinically significant difference
Not all patients will achieve double-digit percentage weight loss
Trejeeve (Tre) Martyn, Beyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor Agonists, we highlight how these therapies are reshaping care across the cardiometabolic spectrum, including obesity, ASCVD, HFpEF, CKD, MASLD/MASH, and obstructive sleep apnea
Adriaenssens AE, Biggs EK, Darwish T et al (2019) Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake